Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Eli Lilly and Company LLY reported fourth-quarter 2024 adjusted earnings per share (“EPS”) of $5.32, which beat the Zacks ...

"Eli Lilly has made an application to SAHPRA for the chronic weight loss indication for Mounjaro and this is pending SAHPRA review," Nicolaou told Spotlight. Mounjaro is sold in pens containing 2.5mg, ...

In a recent episode of "The Oprah Podcast", she said that she took a GLP-1 agonist, which is a specific type of weight-loss medication. Some brand name GLP-1s include Ozempic and Trulicity ...

19.5% weight loss with 10mg and 20.9% weight loss with 15mg. And reviews from people who have used the pen through Phlo Clinic endorse the studies, with one female saying: "I have lost two stone ...